Literature DB >> 27993747

Accuracy of an automated knowledge base for identifying drug adverse reactions.

E A Voss1, R D Boyce2, P B Ryan3, J van der Lei4, P R Rijnbeek4, M J Schuemie5.   

Abstract

INTRODUCTION: Drug safety researchers seek to know the degree of certainty with which a particular drug is associated with an adverse drug reaction. There are different sources of information used in pharmacovigilance to identify, evaluate, and disseminate medical product safety evidence including spontaneous reports, published peer-reviewed literature, and product labels. Automated data processing and classification using these evidence sources can greatly reduce the manual curation currently required to develop reference sets of positive and negative controls (i.e. drugs that cause adverse drug events and those that do not) to be used in drug safety research.
METHODS: In this paper we explore a method for automatically aggregating disparate sources of information together into a single repository, developing a predictive model to classify drug-adverse event relationships, and applying those predictions to a real world problem of identifying negative controls for statistical method calibration.
RESULTS: Our results showed high predictive accuracy for the models combining all available evidence, with an area under the receiver-operator curve of ⩾0.92 when tested on three manually generated lists of drugs and conditions that are known to either have or not have an association with an adverse drug event.
CONCLUSIONS: Results from a pilot implementation of the method suggests that it is feasible to develop a scalable alternative to the time-and-resource-intensive, manual curation exercise previously applied to develop reference sets of positive and negative controls to be used in drug safety research. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse drug reaction; Health outcome; Knowledge base; Machine-learning experiment; Pharmacovigilance

Mesh:

Year:  2016        PMID: 27993747      PMCID: PMC5316295          DOI: 10.1016/j.jbi.2016.12.005

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  31 in total

1.  Text mining for adverse drug events: the promise, challenges, and state of the art.

Authors:  Rave Harpaz; Alison Callahan; Suzanne Tamang; Yen Low; David Odgers; Sam Finlayson; Kenneth Jung; Paea LePendu; Nigam H Shah
Journal:  Drug Saf       Date:  2014-10       Impact factor: 5.606

2.  Adverse event detection in drug development: recommendations and obligations beyond phase 3.

Authors:  Jesse A Berlin; Susan C Glasser; Susan S Ellenberg
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

3.  The EU-ADR project: preliminary results and perspective.

Authors:  Gianluca Trifiro; Annie Fourrier-Reglat; Miriam C J M Sturkenboom; Carlos Díaz Acedo; Johan Van Der Lei
Journal:  Stud Health Technol Inform       Date:  2009

4.  Developing the Sentinel System--a national resource for evidence development.

Authors:  Rachel E Behrman; Joshua S Benner; Jeffrey S Brown; Mark McClellan; Janet Woodcock; Richard Platt
Journal:  N Engl J Med       Date:  2011-01-12       Impact factor: 91.245

5.  Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project.

Authors:  Paul Avillach; Jean-Charles Dufour; Gayo Diallo; Francesco Salvo; Michel Joubert; Frantz Thiessard; Fleur Mougin; Gianluca Trifirò; Annie Fourrier-Réglat; Antoine Pariente; Marius Fieschi
Journal:  J Am Med Inform Assoc       Date:  2012-11-29       Impact factor: 4.497

Review 6.  Assessing cardiovascular drug safety for clinical decision-making.

Authors:  Raymond L Woosley; Klaus Romero
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

Review 7.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

8.  A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.

Authors:  Preciosa M Coloma; Paul Avillach; Francesco Salvo; Martijn J Schuemie; Carmen Ferrajolo; Antoine Pariente; Annie Fourrier-Réglat; Mariam Molokhia; Vaishali Patadia; Johan van der Lei; Miriam Sturkenboom; Gianluca Trifirò
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

9.  Interpreting observational studies: why empirical calibration is needed to correct p-values.

Authors:  Martijn J Schuemie; Patrick B Ryan; William DuMouchel; Marc A Suchard; David Madigan
Journal:  Stat Med       Date:  2013-07-30       Impact factor: 2.373

10.  A curated and standardized adverse drug event resource to accelerate drug safety research.

Authors:  Juan M Banda; Lee Evans; Rami S Vanguri; Nicholas P Tatonetti; Patrick B Ryan; Nigam H Shah
Journal:  Sci Data       Date:  2016-05-10       Impact factor: 6.444

View more
  38 in total

1.  Applied comparison of large-scale propensity score matching and cardinality matching for causal inference in observational research.

Authors:  Stephen P Fortin; Stephen S Johnston; Martijn J Schuemie
Journal:  BMC Med Res Methodol       Date:  2021-05-24       Impact factor: 4.615

2.  How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.

Authors:  Martijn J Schuemie; M Soledad Cepeda; Marc A Suchard; Jianxiao Yang; Yuxi Tian; Alejandro Schuler; Patrick B Ryan; David Madigan; George Hripcsak
Journal:  Harv Data Sci Rev       Date:  2020-01-31

3.  Evaluating large-scale propensity score performance through real-world and synthetic data experiments.

Authors:  Yuxi Tian; Martijn J Schuemie; Marc A Suchard
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

4.  Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications.

Authors:  Justin Mower; Devika Subramanian; Trevor Cohen
Journal:  J Am Med Inform Assoc       Date:  2018-10-01       Impact factor: 4.497

5.  ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model.

Authors:  Yue Yu; Kathryn J Ruddy; Na Hong; Shintaro Tsuji; Andrew Wen; Nilay D Shah; Guoqian Jiang
Journal:  J Biomed Inform       Date:  2019-02-07       Impact factor: 6.317

Review 6.  Representing Knowledge Consistently Across Health Systems.

Authors:  S T Rosenbloom; R J Carroll; J L Warner; M E Matheny; J C Denny
Journal:  Yearb Med Inform       Date:  2017-09-11

7.  Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug Surveillance.

Authors:  Justin Mower; Trevor Cohen; Devika Subramanian
Journal:  Drug Saf       Date:  2020-01       Impact factor: 5.606

8.  Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data.

Authors:  Martijn J Schuemie; George Hripcsak; Patrick B Ryan; David Madigan; Marc A Suchard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-13       Impact factor: 11.205

9.  Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Seng Chan You; Yeunsook Rho; Behnood Bikdeli; Jiwoo Kim; Anastasios Siapos; James Weaver; Ajit Londhe; Jaehyeong Cho; Jimyung Park; Martijn Schuemie; Marc A Suchard; David Madigan; George Hripcsak; Aakriti Gupta; Christian G Reich; Patrick B Ryan; Rae Woong Park; Harlan M Krumholz
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272

10.  Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.

Authors:  Marc A Suchard; Martijn J Schuemie; Harlan M Krumholz; Seng Chan You; RuiJun Chen; Nicole Pratt; Christian G Reich; Jon Duke; David Madigan; George Hripcsak; Patrick B Ryan
Journal:  Lancet       Date:  2019-10-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.